IAM insider buying
Every open-market purchase of Iambic Therapeutics, Inc. (IAM) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$11.50M
Insiders buying (12m)1
Purchases on record1
Last purchase filedOct 19, 2026
In the last 12 months, 1 insider of Iambic Therapeutics, Inc. bought $11.50M of IAM stock on the open market in 1 reported purchase. The most recent was filed on Oct 19, 2026: Rachlin Evan Lockwood (Director) bought 718,750 shares at $16.00, worth $11.50M.
Get the next IAM insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll IAM insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Oct 19 | Rachlin Evan LockwoodDirector | $11.50M | 718,750 | $16.00 | +38% | Oct 16 | SEC |